Identifying adults at low risk for significant hyperlipidemia: A validated clinical index

Journal of Clinical Epidemiology

Volumn 52, Issue 1, 1999, Pages 49-55

  Grover, Steven A ^a,b,c,d,e   Levinton, Carey ^a   Paquet, Steeve ^a  

^a Ctr Anal of Cost Effective Care   (Canada)

^b Divisions of Cardiology and of General Internal Medicine   (Canada)

^c MONTREAL GENERAL HOSPITAL   (Canada)

^d Departments of Medicine   (Canada)

^e MCGILL UNIVERSITY   (Canada)

Author keywords

Clinical index; Coronary disease; Hyperlipidemia; Risk prediction

Indexed keywords

ARTICLE; CHOLESTEROL BLOOD LEVEL; COMORBIDITY; DIABETES MELLITUS; HUMAN; HYPERLIPIDEMIA; PHYSICAL ACTIVITY; PRIORITY JOURNAL; REGRESSION ANALYSIS; RISK ASSESSMENT; RISK FACTOR; SCREENING TEST; SEX DIFFERENCE; SYSTOLIC BLOOD PRESSURE;

EID: 0032897404     PISSN: 08954356     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0895-4356(98)00139-5     Document Type: Article

References (31)

1. Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults. Summary of the Second Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel II). JAMA 1993; 269: 3015-3023.
2. The Canadian Consensus Conference on Cholesterol: Final Report: The Canadian Consensus Conference on the prevention of heart and vascular disease by altering serum cholesterol and lipoprotein risk factors. Can Med Assoc J 1988; 139(Suppl 11): 1-8.
3. Garber AM, Littenberg B, Sox HC. Cost and effectiveness of cholesterol screening in the elderly. Health Program Office of Technology Assessment. Washington, D.C.: U.S. Government Printing Office; 1989: 35-40.
4. Grover S.A., Coupal L., Fakhry R., Suissa S. Screening for hypercholesterolemia among Canadians. How much will it cost? Can Med Assoc J. 144(2):1991;161-168.
5. Grover S.A., Palmer C.S., Coupal L. Serum lipid screening to identify high-risk individuals for coronary death. Arch Intern Med. 154:1994;679-684.
6. Grover S.A., Coupal L., Hu X.-P. Identifying adults at increased risk of coronary disease. How well do the current cholesterol guidelines work? JAMA. 274(10):1995;801-806.
7. Stampfer M.J., Sacks F.M., Salvini S., Willett W.C., Hennekens C.H. A prospective study of cholesterol, apolipoproteins, and the risk of myocardial infarction. N Engl J Med. 325(6):1991;373-381.
8. Castelli W.P., Anderson K. A population at risk. Prevalence of high cholesterol levels in hypertensive patients in the Framingham Study Am J Med. 80(Suppl 2A):1986;23-32.
9. Brunner D., Weisbort J., Meshulam N.et al. Relation of serum total cholesterol and high-density lipoprotein cholesterol percentage to the incidence of definite coronary events. Twenty-year follow-up of the Donolo-Tel Aviv Prospective Coronary Artery Disease Study Am J Cardiol. 59:1987;1271-1276.
10. Goldbourt G., Holtzman E., Neufeld H.N. Total and high density lipoprotein cholesterol in the serum and risk of mortality. Evidence of a threshold effect Br Med J. 290:1985;1239-1243.
11. Ciampi A., Negassa A., Lou Zihyi Tree-structured prediction for censored survival data and the Cox model. J Clin Epidemiol. 48:1995;675-689.
12. Goulet J.R., Mackenzie T., Levinton C.M., Hayslett J.P., Ciampi A., Esdaile J.M. The longterm prognosis of lupus nephritis. The impact of disease activity J Rheumatol. 20:1993;59-65.
13. Central Patient Registry and Coordinating Center for the Lipid Research Clinics. Reference Manual for the Lipid Research Clinics Prevalence Study, Vols. 1 and 2. Chapel Hill, NC: Dept of Biostatistics, University of North Carolina; February 1974.
14. Lipid Research Clinics Program Epidemiology Committee Plasma lipid distributions in selected North American populations. The Lipid Research Clinics Prevalence Study Circulation. 60:1979;427-439.
15. Heiss G., Tamir I., Davis C.E.et al. Lipoprotein-cholesterol distributions in selected North American populations. The Lipid Research Clinics Program Prevalence Study Circulation. 61:1980;302-315.
16. Lipid Research Clinics Program. Manual of Laboratory Operations, Vol. 1: Lipid and Lipoprotein Analysis. Bethesda, MD: National Heart, Lung, and Blood Institute, National Institutes of Health; 1974. US Dept of Health, Education, and Welfare publication (NIH) 75-628.
17. Jacobs D.R. Jr., Melbane I.L., Bangdiwala S.I., Criqui M.H., Tyroler H.A. Lipid Research Clinics Program. High density lipoprotein cholesterol as a predictor of cardiovascular disease mortality in men and women. The follow-up study of the Lipid Research Clinics Prevalence Study Am J Epidemiol. 131:1990;32-47.
18. Caroll MC, Sempos C, Briefel R, Gray S, Johnson C. Serum lipids of adults 20-74 years. United States, 1976-80. National Centre for Health Statistics. Vital Health Stat 11(242). 1993.
19. Esrey KL, Coupal L, Grover SA. Évaluation du risque de maladies cardiovasculaires. Exemple d'application d'une méthode multifactorielle. In: Santé Québec: Et votre coeur, ça va? Rapport de l'Enquête québécoise sur la santé cardiovasculaire 1990. Montréal, ministère de la Santé et des Services sociaux, gouvernement du Québec; 1994: 95-101.
20. Heiss G., Johnson N.J., Reiland S., Davis C.E., Tyroler H.A. The epidemiology of plasma high-density lipoprotein cholesterol levels. The Lipid Research Clinics Program Prevalence Study: Summary Circulation. 62(Suppl IV):1980;116-136.
21. Ernst N., Fisher M., Smith W.et al. The association of plasma high-density lipoprotein cholesterol with dietary intake and alcohol consumption. The Lipid Research Clinics Program Prevalence Study Circulation. 62(Suppl IV):1980;41-52.
22. Anderson K.M., Wilson P.W., Garrison R.J., Castelli W.P. Longitudinal and secular trends in lipoprotein cholesterol measurements in a general population sample. The Framingham Offspring Study Atherosclerosis. 68:1987;59-66.
23. Dwyer T., Calvert G.D., Baghurst K.I., Leitch D.R. Diet, other lifestyle factors and HDL cholesterol in a population of Australian male service recruits. Am J Epidemiol. 114:1981;683-696.
24. Wolfe R.N., Grundy S.M. Influence of weight reduction on plasma lipoproteins in obese patients. Arteriosclerosis. 3:1983;160-168.
25. Wood P.D., Klein H., Lewis S., Haskell W.L. The distribution of plasma lipoproteins in middle aged male runners. Metabolism. 25:1976;1249-1254.
26. Stein R.A., Michielli D.W., Glantz M.D.et al. Effects of different exercise training intensities on lipoprotein cholesterol fractions in healthy middle-aged men. Am Heart J. 119(2):1990;277-283.
27. Howard B.V. Lipoprotein metabolism in diabetes mellitus. J Lipid Res. 28:1987;613-628.
28. Goldman L., Caldera D.L., Nussbaum S.R.et al. Multifactorial index of cardiac risk in noncardiac surgical procedures. N Engl J Med. 297(16):1977;845-850.
29. Stiell I.G., McKnight R.D., Greenberg G.H.et al. Implementation of the Ottawa Ankle Rules. JAMA. 271(11):1994;827-832.
30. Marcantonio E.R., Goldman L., Mangione C.M.et al. A clinical prediction rule for delirium after elective noncardiac surgery. JAMA. 271(2):1994;134-139.
31. Kinlay S., Heller R.F. Selective screening for high cholesterol in Australian general practice. The Newcastle Cholesterol Prediction Study J Gen Int Med. 5:1990;1-8.